CDK9 as a Valuable Target in Cancer: From Natural Compounds Inhibitors to Current Treatment in Pediatric Soft Tissue Sarcomas

被引：29

作者：

Cassandri, Matteo ^{[1
]}

Fioravanti, Rossella ^{[2
]}

Pomella, Silvia ^{[1
]}

Valente, Sergio ^{[2
]}

Rotili, Dante ^{[2
]}

Del Baldo, Giada ^{[1
]}

De Angelis, Biagio ^{[1
]}

Rota, Rossella ^{[1
]}

Mai, Antonello ^{[2
]}

机构：

[1] IRCCS, Dept Oncohematol, Bambino Gesu Childrens Hosp, Rome, Italy

[2] Sapienza Univ Rome, Dept Drug Chem & Technol, Rome, Italy

来源：

FRONTIERS IN PHARMACOLOGY | 2020年 / 11卷

关键词：

natural inhibitors; CDK9; pediatric sarcoma; gene transcription; chromosomal translocation; DEPENDENT KINASE INHIBITOR; CELL-CYCLE ARREST; INACTIVE P-TEFB; SYNOVIAL SARCOMA; TRANSCRIPTIONAL ELONGATION; 7SK SNRNP; RHABDOMYOSARCOMA; FLAVOPIRIDOL; ACTIVATION; COMPLEX;

D O I：

10.3389/fphar.2020.01230

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Cyclin-Dependent Kinases (CDKs) are well-known reliable targets for cancer treatment being often deregulated. Among them, since the transcription-associated CDK9 represents the sentry of cell transcriptional homeostasis, it can be a valuable target for managing cancers in which the transcriptional machinery is dysregulated by tumor-driver oncogenes. Here we give an overview of some natural compounds identified as CDK inhibitors with reported activity also against CDK9, that were taken as a model for the development of highly active synthetic anti-CDK9 agents. After, we summarize the data on CDK9 inhibition in a group of rare pediatric solid tumors such as rhabdomyosarcoma, Ewing's sarcoma, synovial sarcoma and malignant rhabdoid tumors (soft tissue sarcomas), highlighting the more recent results in this field. Finally, we discuss the perspective and challenge of CDK9 modulation in cancer.

引用

页数：12

共 96 条

[1] Promoter-proximal pausing of RNA polymerase II: emerging roles in metazoans [J].

Adelman, Karen ;

Lis, John T. .

NATURE REVIEWS GENETICS, 2012, 13 (10) :720-731

[2] Characterization of molecular and cellular functions of the cyclin-dependent kinase CDK9 using a novel specific inhibitor [J].

Albert, T. K. ;

Rigault, C. ;

Eickhoff, J. ;

Baumgart, K. ;

Antrecht, C. ;

Klebl, B. ;

Mittler, G. ;

Meisterernst, M. .

BRITISH JOURNAL OF PHARMACOLOGY, 2014, 171 (01) :55-68

[3] New Strategies in Ewing Sarcoma: Lost in Translation? [J].

Arnaldez, Fernanda I. ;

Helman, Lee J. .

CLINICAL CANCER RESEARCH, 2014, 20 (12) :3050-3056

[4] CDK9: a signaling hub for transcriptional control [J].

Bacon, Curtis W. ;

D'Orso, Ivan .

TRANSCRIPTION-AUSTIN, 2019, 10 (02) :57-75

[5] NF-κB binds P-TEFb to stimulate transcriptional elongation by RNA polymerase II [J].

Barboric, M ;

Nissen, RM ;

Kanazawa, S ;

Jabrane-Ferrat, N ;

Peterlin, BM .

MOLECULAR CELL, 2001, 8 (02) :327-337

[6] The structure of P-TEFb (CDK9/cyclin T1), its complex with flavopiridol and regulation by phosphorylation [J].

Baumli, Sonja ;

Lolli, Graziano ;

Lowe, Edward D. ;

Troiani, Sonia ;

Rusconi, Luisa ;

Bullock, Alex N. ;

Debreczeni, Judit E. ;

Knapp, Stefan ;

Johnson, Louise N. .

EMBO JOURNAL, 2008, 27 (13) :1907-1918

[7] Meriolins, a new class of cell death-inducing kinase inhibitors with enhanced selectivity for cyclin-dependent kinases [J].

Bettayeb, Karima ;

Tirado, Oscar M. ;

Marionneau-Lambot, Severine ;

Ferandin, Yoan ;

Lozach, Olivier ;

Morris, Jonathan C. ;

Mateo-Lozano, Silvia ;

Drueckes, Peter ;

Schaechtele, Christoph ;

Kubbutat, Michael H. G. ;

Liger, Francois ;

Marquet, Bernard ;

Joseph, Benoit ;

Echalier, Aude ;

Endicott, Jane A. ;

Notario, Vicente ;

Meijer, Laurent .

CANCER RESEARCH, 2007, 67 (17) :8325-8334

[8] Discovery of Wogonin-based PROTACs against CDK9 and capable of achieving antitumor activity [J].

Bian, Jinlei ;

Ren, Jie ;

Li, Yongren ;

Wang, Jubo ;

Xu, Xi ;

Feng, Yifan ;

Tang, Hui ;

Wang, Yajing ;

Li, Zhiyu .

BIOORGANIC CHEMISTRY, 2018, 81 :373-381

[9] Flavopiridol inactivates P-TEFb and blocks most RNA polymerase II transcription in vivo [J].

Chao, SH ;

Price, DH .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (34) :31793-31799

[10] PP2B and PP1α cooperatively disrupt 7SK snRNP to release P-TEFb for transcription in response to Ca2+ signaling [J].

Chen, Ruichuan ;

Liu, Min ;

Li, Huan ;

Xue, Yuhua ;

Ramey, Wanichaya N. ;

He, Nanhai ;

Ai, Nanping ;

Luo, Haohong ;

Zhu, Ying ;

Zhou, Nan ;

Zhou, Qiang .

GENES & DEVELOPMENT, 2008, 22 (10) :1356-1368

← 1 2 3 4 5 6 7 8 9 10 →